Although it remains to be seen if the PPARγ agonism produces the same side effects that make currently available PPARγ agonists undesirable, such as weight gain, increased fluid retention, and a higher risk for the development of congestive heart failure.686. The gene discussed is PPARG; the disease is congestive heart failure.